The pharmaceutical equipment industry has started a new journey, and the transformation and upgrading are accelerating

Affected by favorable policies, expanding market demand, accelerated transformation of the pharmaceutical industry and other factors, the pharmaceutical equipment industry, which is closely related to pharmaceutical production, has also ushered in a good opportunity for development.
While the market size has continued to grow, significant changes have also taken place in development
.
The pharmaceutical equipment industry has embarked on a new journey, and its transformation and upgrading are accelerating (Photo source: Pharmaceutical Network) In the past, China's pharmaceutical equipment manufacturers had a small number of pharmaceutical equipment manufacturers, and most of them mainly produced single equipment, relying on low-level repeated production
.
However, with the fierce competition in the pharmaceutical equipment market and the changing needs of users of pharmaceutical companies, it is difficult for a single device to meet the needs of pharmaceutical companies.
The product pipeline is continuously enriched to meet the new requirements of users, and further enhance the competitiveness of enterprises and obtain profits
.
At present, with the rapid development of the pharmaceutical industry, the pharmaceutical equipment industry has gradually shifted from a cyclical industry dominated by the original GMP policy and dominated by a single equipment to a "diversified equipment + multi-category consumables + personalized service" drive high-prosperity growth industries
.
It is worth noting that due to the current diversified development of domestic pharmaceutical equipment companies mainly reflected in the adjustment of product lines, the extension of the industrial chain and the improvement of services; affected by this, high-end and intelligent models have become numerous.
Areas where companies are competing for layout
.
For example, Canaan Technology has clearly stated before that the next step will be to build a two-way "factory of the future" from digital twin technology, intelligent production, digital management, networked collaboration, and personalized customization.
At the same time, the company will also strive to improve Intelligent and whole-line engineering design capabilities provide users with more high value-added services
.
However, despite the vigorous promotion of Industry 4.
0, new infrastructure, and intelligent manufacturing, this transformation direction has become a major trend
.
However, from the current point of view, the level of domestic pharmaceutical companies in information investment and other aspects still needs to be improved
.
According to data, less than 5% of the more than 4,000 drug production enterprises in the country fully use computer control, and most of them still use semi-automatic and manual production technology, which makes the controllability of drugs low and the quality difficult to maintain stable and consistent.

.
Therefore, the industry believes that in the future, enterprises in the pharmaceutical equipment industry need to further explore clear industry development trends and new needs of market users, based on a new starting point, formulate new plans and new directions, continue to climb rocks, and continue to accelerate the pace of transformation and upgrading
.
In addition to the transformation to diversification and digitization, the pace of domestic pharmaceutical equipment products going overseas has actually been accelerating
.
Taking Liaoning Chunguang as an example, its short-term development goals set earlier clearly mentioned that by 2025, when the company's vision and planning are fully realized, it will strive to account for 50% of international sales and domestic sales, and achieve both.
Big and stronger situation
.
In addition, through relying on its own research and development and extensional mergers and acquisitions in recent years, Chutian Technology has begun to take shape in its strategic layout, and its strategic effect has also initially appeared
.
According to its 2020 annual report, in 2020, the company's overseas performance achieved steady growth, with foreign revenue increasing by 6.
63% year-on-year
.
Among them, ROMACO company achieved a net profit of 73.
7226 million yuan for the year, exceeding the performance target with a completion rate of 133.
73%
.
The industry believes that the accelerated expansion of the international market has now become a distinctive feature of the domestic pharmaceutical equipment industry
.
The growing overseas revenue market of domestic pharmaceutical equipment companies not only reflects the accelerated internationalization of domestic pharmaceutical equipment, but also reflects the international recognition of domestic pharmaceutical equipment in terms of quality, technology, and services
.